The Asia Pacific Endoscopy Fluid Management Market should witness market growth of 7.6% CAGR during the forecast period (2022-2028).
The patient might receive anesthesia during the procedure, depending on the endoscopy type. Anesthesia blocks the awareness of pain and keeps the patient drowsy, awake, or asleep during the process. While the patient receives anesthesia, their healthcare team will provide anesthesia care, which includes monitoring the temperature, heart rate, and blood pressure. The doctor will review and possibly record images from the endoscopy during the procedure.
They will also perform any procedures, which include collecting tissue for testing. For most endoscopic procedures, the patients don’t require to stay in the hospital overnight. New techniques constantly make endoscopy more comfortable for people. Disease diagnosis is also made easier for doctors. New endoscopic procedures include virtual endoscopy. Different from a standard endoscopy, the doctor does not insert an endoscope into the body. These tests contain a computed tomography (CT) scans of the body’s thin segments.
In India, illness and disease of the gastrointestinal system have increased in the last decade due to the change in many lifestyles. People with gastrointestinal disorders have a high prevalence of stress, anxiety, and impaired central nervous system functioning. The net prevalence of depression of self-reported gastrointestinal problems was 18% with prominent variations, and it also increased with the increasing age of individuals. The growing prevalence of gastrointestinal diseases and the rising healthcare infrastructure in the region is anticipated to increase the availability of better products and the wider usage of endoscopy fluid management, which will drive the market expansion in the Asia Pacific.
The China market dominated the Asia Pacific Endoscopy Fluid Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $79.6 Million by 2028. The Japan market is estimated to grow a CAGR of 7% during (2022-2028). Additionally, The India market would experience a CAGR of 8.3% during (2022-2028).
Based on Application, the market is segmented into Laparoscopy, Hysterroscopy and Others. Based on Product, the market is segmented into System and Accessories. Based on End-user, the market is segmented into Hospital, Clinics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
The patient might receive anesthesia during the procedure, depending on the endoscopy type. Anesthesia blocks the awareness of pain and keeps the patient drowsy, awake, or asleep during the process. While the patient receives anesthesia, their healthcare team will provide anesthesia care, which includes monitoring the temperature, heart rate, and blood pressure. The doctor will review and possibly record images from the endoscopy during the procedure.
They will also perform any procedures, which include collecting tissue for testing. For most endoscopic procedures, the patients don’t require to stay in the hospital overnight. New techniques constantly make endoscopy more comfortable for people. Disease diagnosis is also made easier for doctors. New endoscopic procedures include virtual endoscopy. Different from a standard endoscopy, the doctor does not insert an endoscope into the body. These tests contain a computed tomography (CT) scans of the body’s thin segments.
In India, illness and disease of the gastrointestinal system have increased in the last decade due to the change in many lifestyles. People with gastrointestinal disorders have a high prevalence of stress, anxiety, and impaired central nervous system functioning. The net prevalence of depression of self-reported gastrointestinal problems was 18% with prominent variations, and it also increased with the increasing age of individuals. The growing prevalence of gastrointestinal diseases and the rising healthcare infrastructure in the region is anticipated to increase the availability of better products and the wider usage of endoscopy fluid management, which will drive the market expansion in the Asia Pacific.
The China market dominated the Asia Pacific Endoscopy Fluid Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $79.6 Million by 2028. The Japan market is estimated to grow a CAGR of 7% during (2022-2028). Additionally, The India market would experience a CAGR of 8.3% during (2022-2028).
Based on Application, the market is segmented into Laparoscopy, Hysterroscopy and Others. Based on Product, the market is segmented into System and Accessories. Based on End-user, the market is segmented into Hospital, Clinics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
Scope of the Study
By Application
- Laparoscopy
- Hysterroscopy
- Others
By Product
- System
- Accessories
By End-user
- Hospital
- Clinics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Olympus Corporation
- Steris PLC
- B.Braun Melsungen AG
- Stryker Corporation
- Hologic, Inc.
- ConMed Corporation
- Karl Storz SE & Co. KG
- Arthrex, Inc.
- COMEG Medical Technologies (Acteon Group)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Endoscopy Fluid Management Market, by Application
1.4.2 Asia Pacific Endoscopy Fluid Management Market, by Product
1.4.3 Asia Pacific Endoscopy Fluid Management Market, by End User
1.4.4 Asia Pacific Endoscopy Fluid Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Endoscopy Fluid Management Market by Application
4.1 Asia Pacific Laparoscopy Market by Country
4.2 Asia Pacific Hysterroscopy Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Endoscopy Fluid Management Market by Product
5.1 Asia Pacific System Market by Country
5.2 Asia Pacific Accessories Market by Country
Chapter 6. Asia Pacific Endoscopy Fluid Management Market by End User
6.1 Asia Pacific Hospital Market by Country
6.2 Asia Pacific Clinics Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Endoscopy Fluid Management Market by Country
7.1 China Endoscopy Fluid Management Market
7.1.1 China Endoscopy Fluid Management Market by Application
7.1.2 China Endoscopy Fluid Management Market by Product
7.1.3 China Endoscopy Fluid Management Market by End User
7.2 Japan Endoscopy Fluid Management Market
7.2.1 Japan Endoscopy Fluid Management Market by Application
7.2.2 Japan Endoscopy Fluid Management Market by Product
7.2.3 Japan Endoscopy Fluid Management Market by End User
7.3 India Endoscopy Fluid Management Market
7.3.1 India Endoscopy Fluid Management Market by Application
7.3.2 India Endoscopy Fluid Management Market by Product
7.3.3 India Endoscopy Fluid Management Market by End User
7.4 South Korea Endoscopy Fluid Management Market
7.4.1 South Korea Endoscopy Fluid Management Market by Application
7.4.2 South Korea Endoscopy Fluid Management Market by Product
7.4.3 South Korea Endoscopy Fluid Management Market by End User
7.5 Singapore Endoscopy Fluid Management Market
7.5.1 Singapore Endoscopy Fluid Management Market by Application
7.5.2 Singapore Endoscopy Fluid Management Market by Product
7.5.3 Singapore Endoscopy Fluid Management Market by End User
7.6 Malaysia Endoscopy Fluid Management Market
7.6.1 Malaysia Endoscopy Fluid Management Market by Application
7.6.2 Malaysia Endoscopy Fluid Management Market by Product
7.6.3 Malaysia Endoscopy Fluid Management Market by End User
7.7 Rest of Asia Pacific Endoscopy Fluid Management Market
7.7.1 Rest of Asia Pacific Endoscopy Fluid Management Market by Application
7.7.2 Rest of Asia Pacific Endoscopy Fluid Management Market by Product
7.7.3 Rest of Asia Pacific Endoscopy Fluid Management Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Product launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Olympus Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.2.4.3 Acquisition and Mergers:
8.3 Steris PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 B. Braun Melsungen AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Stryker Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.6 Hologic, Inc
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 ConMed Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.8 Karl Storz SE & Co. KG
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.9 Arthrex, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Geographical Expansions:
8.10. COMEG Medical Technologies (Acteon Group)
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Olympus Corporation
- Steris PLC
- B. Braun Melsungen AG
- Stryker Corporation
- Hologic, Inc.
- ConMed Corporation
- Karl Storz SE & Co. KG
- Arthrex, Inc.
- COMEG Medical Technologies (Acteon Group)
Methodology
LOADING...
